Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Trial details
- Registry ID
- NCT07457918
- Drugs studied
- Cantharidin
TrialRedline tracks 6 clinical trials sponsored by Verrica Pharmaceuticals Inc.: 3 Phase 3, 3 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)NCT07457918 | Cantharidin | Recruiting | 2027-11Estimated |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)NCT07637734 | VP-102 (US) / TO-208 (Japan), Vehicle (US) / Vehicle (Japan) | Recruiting | 2027-05Estimated |
| Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)NCT07246590 | VP-102, Vehicle | Active not recruiting | 2026-11Estimated |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaNCT05188729 | Part 1: VP-315 3 Day Dosing/Week, Part 2: VP-315 2 Day Dosing/Week - Split Dose, Part 2: VP-315 3 Day Dosing/Week - Loading Dose, Part 2: VP-315 3 Day Dosing/Week - No Loading Dose and 1 more | Completed | 2024-04-15Actual |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsNCT03981822 | VP-102 and applicator | Completed | 2020-05-21Actual |
| Cantharidin and Occlusion in Verruca EpitheliumNCT03487549 | VP-102 Cantharidin topical film forming solution, VP-102 Cantharidin, topical film forming solution | Completed | 2019-05-16Actual |
Names as written in the registry records.
NCT07246590 · Verrica Pharmaceuticals Inc.
Before: Estimated. After: Actual.
Before: 300 participants (planned). After: 302 participants (actual).
Before: Jun 2027. After: Nov 2026.
Before: Recruiting. After: Active not recruiting.
NCT07457918 · Verrica Pharmaceuticals Inc.
Before: 600 participants (planned). After: 250 participants (planned).
Before: 30 Apr 2028. After: Nov 2027.
NCT07637734 · Verrica Pharmaceuticals Inc.
Before: Aug 2027. After: May 2027.
Before: Not yet recruiting. After: Recruiting.
NCT07457918 · Verrica Pharmaceuticals Inc.
Before: Not yet recruiting. After: Recruiting.
NCT07246590 · Verrica Pharmaceuticals Inc.
Before: Not yet recruiting. After: Recruiting.